LS Investment Advisors’s AstraZeneca AZN Stock Holding History

LS Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-670	Closed	-$53K	–	1710
2018 Q3	$53K	Hold	670	–	–	﹤0.01%	1308
2018 Q2	$47K	Hold	670	–	–	﹤0.01%	1331
2018 Q1	$47K	Hold	670	–	–	﹤0.01%	1312
2017 Q4	$46K	Hold	670	–	–	﹤0.01%	1329
2017 Q3	$45K	Hold	670	–	–	﹤0.01%	1387
2017 Q2	$46K	Hold	670	–	–	﹤0.01%	1368
2017 Q1	$42K	Hold	670	–	–	﹤0.01%	1379
2016 Q4	$37K	Hold	670	–	–	﹤0.01%	1367
2016 Q3	$44K	Hold	670	–	–	﹤0.01%	1269
2016 Q2	$40K	Hold	670	–	–	﹤0.01%	1280
2016 Q1	$38K	Hold	670	–	–	﹤0.01%	1271
2015 Q4	$45K	Hold	670	–	–	﹤0.01%	1190
2015 Q3	$43K	Hold	670	–	–	﹤0.01%	1203
2015 Q2	$43K	Hold	670	–	–	﹤0.01%	1240
2015 Q1	$46K	Hold	670	–	–	﹤0.01%	702
2014 Q4	$47K	Hold	670	–	–	﹤0.01%	707
2014 Q3	$48K	Hold	670	–	–	﹤0.01%	701
2014 Q2	$50K	Hold	670	–	–	﹤0.01%	698
2014 Q1	$43K	Hold	670	–	–	﹤0.01%	699
2013 Q4	$40K	Hold	670	–	–	﹤0.01%	714
2013 Q3	$35K	Hold	670	–	–	﹤0.01%	587
2013 Q2	$32K	Buy	+670	New	+$34.1K	﹤0.01%	421

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

LS Investment Advisors's AZN Position: Q4 2018 in Review

LS Investment Advisors sold out of AstraZeneca (AZN) in Q4 2018, closing a stake of 670 shares — an estimated $53K sold.

LS Investment Advisors first reported a position in AZN in Q2 2013 and held it in 22 quarters. The position peaked at $53K in Q3 2018. 557 funds tracked by Wall St. Rank hold AZN as of Q4 2018.

LS Investment Advisors reported no remaining AstraZeneca position as of Q4 2018 after selling out during the quarter.
LS Investment Advisors sold 670 AstraZeneca shares in Q4 2018, an estimated $53K.
LS Investment Advisors first reported a position in AstraZeneca in Q2 2013 and held it in 22 quarters.
LS Investment Advisors's AstraZeneca position peaked at $53K in Q3 2018.
557 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2018.

Based on LS Investment Advisors's 13F filing for Q4 2018, filed 1 Feb 2019.